His primary scientific interests are in Psychiatry, Substance abuse, Methadone, Cohort study and Randomized controlled trial. The Psychiatry study combines topics in areas such as Family medicine, Public health and Mass screening. His Substance abuse research includes themes of Nursing, Mental health, Response rate and Smoking cessation.
His Cohort study study combines topics in areas such as Ambulatory care, Heroin, Emergency department, Emergency medicine and Methadone maintenance. His research in Randomized controlled trial intersects with topics in Physical therapy, Blood pressure and Veterans Affairs. His studies examine the connections between Abstinence and genetics, as well as such issues in Buprenorphine, with regards to Anesthesia and Internal medicine.
His scientific interests lie mostly in Psychiatry, Substance abuse, Family medicine, Public health and Randomized controlled trial. His work on Mental health, Methadone and Addiction as part of his general Psychiatry study is frequently connected to Criminal justice, thereby bridging the divide between different branches of science. He interconnects Nursing, Buprenorphine and Ambulatory care in the investigation of issues within Methadone.
His Buprenorphine research integrates issues from Anesthesia and Naloxone. As part of the same scientific family, Peter D. Friedmann usually focuses on Substance abuse, concentrating on Clinical psychology and intersecting with Behavior management. Public health and Psychological intervention are commonly linked in his work.
Peter D. Friedmann focuses on Psychiatry, Opioid use disorder, Substance abuse, Criminal justice and Family medicine. His Psychiatry research is multidisciplinary, relying on both Buprenorphine, Randomized controlled trial and Opioid use. As part of one scientific family, Peter D. Friedmann deals mainly with the area of Opioid use disorder, narrowing it down to issues related to the Public health, and often Occupational safety and health and Medical emergency.
He has included themes like Patient-centered care, Health insurance, Randomization, Mental health and Addiction in his Substance abuse study. He works mostly in the field of Family medicine, limiting it down to topics relating to Medicaid and, in certain cases, Addiction medicine and Logistic regression, as a part of the same area of interest. His biological study spans a wide range of topics, including Evidence-based practice and Intensive care medicine.
Peter D. Friedmann mainly focuses on Psychiatry, Intervention, Opioid use disorder, Medicaid and Substance abuse. His work on Methadone is typically connected to Criminal justice as part of general Psychiatry study, connecting several disciplines of science. His work deals with themes such as Addiction medicine, Anesthesia and Quality of life, which intersect with Opioid use disorder.
His research integrates issues of Gerontology, Generalized estimating equation, Retrospective cohort study, Emergency medicine and Health insurance in his study of Medicaid. Peter D. Friedmann has researched Substance abuse in several fields, including Medicaid coverage, Mental health, Patient Protection and Affordable Care Act and Public health. His studies in Randomized controlled trial integrate themes in fields like Economic evaluation, Abstinence, Pediatrics and Naltrexone.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: